Related Experiment Video
Updated: Jun 12, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
[Autoimmune epilepsy]
M Seeck1, A Zacharia, A O Rossetti
1Service de neurologie, HUG, 1211 Genève 14. margitta.seeck@hcuge.ch
Abstract:
There is increasing recognition of an autoimmune origin of pharmacoresistant epileptic disorders. Besides the paraneoplastic limbic encephalopathies (LE), reports of syndromes of non-paraneoplastic LE are increasingly reported in the last 5-10 years. Three antibodies are now relatively well described: Voltage-gated potassium channels (VGKC), glutamic acid decarboxylase (GAD) and N-methyl-D-aspartate receptor-(NMDA) antibodies. We review clinical syndromes, associated imaging and laboratory findings. While most reports arise from adult populations, children and adolescents are also concerned as evidenced by increasing observations. Early recognition is mandatory, since early immunomodulatory treatment appears to be related to significantly better outcome.
Related Concept Videos
Encephalitis l: Introduction
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Encephalitis ll: Pathophysiology
Epilepsy ll: Types
Antiepileptic Drugs: Glutamate Antagonists

